Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02643381 · ClinicalTrials.gov registry record · Phase 4
Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 801
- Enrollment target
NCT02643381: Completed Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
NCT02643381 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 801 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02643381, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 801 participants
- Enrollment target
Study Summary
Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patients who are gravely ill two medications are commonly used: etomidate or ketamine. Both medications have risks and benefits. Researchers at UT-Southwestern Medical Center and Parkland Memorial Hospital would like to do a study to figure out which one is better for our patients.
Primary Outcome
Survival is defined as the number of participants survived at day 7 following emergency endotracheal intubation
Interventions
- DRUG Ketamine
- DRUG Etomidate
- PROCEDURE Emergency Endotracheal Intubation
- DEVICE Mechanical Ventilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 801 participants |
| Start Date | 2016-06-06 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 4 |
What the finished NCT02643381 record still lists
NCT02643381 is an interventional study that assigns participants to a tested intervention. The registered 801 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% higher).
The record links to 0 conditions, and to 4 interventions - of which Ketamine is the first listed.
NCT02643381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02643381 about?
NCT02643381 is a clinical study titled "Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial". Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patien...
What is the current status of trial NCT02643381?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 801 participants. The study started on 2016-06-06. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT02643381?
The interventions under investigation include: Ketamine (DRUG), Etomidate (DRUG), Emergency Endotracheal Intubation (PROCEDURE), Mechanical Ventilation (DEVICE).
Who is sponsoring clinical trial NCT02643381?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02643381's enrollment target sits among peer trials
801 98th of 2000 higher than 1,902 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03524430 · 801 participants · NA
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI